ArticleHematology. American Society of Hematology. Education Program2022

Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic thrombocytopenic purpura?

George Goshua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.